|
|||||
|
|
| 急性心肌梗死生化标志物的研究进展 | |
| 引用本文： | 沈健. 急性心肌梗死生化标志物的研究进展[J]. 心血管病学进展, 2012, 33(1): 106-110 |
| 作者姓名： | 沈健 |
| 作者单位： | 重庆医科大学附属第一医院心血管内科,重庆,400016 |
| 摘 要： | 急性心肌梗死是临床常见的危重疾病,血液中生化标志物的测定是反映心肌损伤的重要手段之一。生化标志物凭其高度的敏感性及特异性,在急性心肌梗死的诊断、危险分层及评估预后中发挥了非常重要的作用。目前已有越来越多的心肌梗死生化标志物在临床中得到应用。现就急性心肌梗死损伤生化标志物的最新研究进展做一综述。 |
| 关 键 词： | 急性心肌梗死 生化标志物 |
Research Advancements for Biomarkers Used in Acute Myocardial Infarction |
|
| SHEN Jian. Research Advancements for Biomarkers Used in Acute Myocardial Infarction[J]. Advances in Cardiovascular Diseases, 2012, 33(1): 106-110 | |
| Authors: | SHEN Jian |
| Affiliation: | (Department of Cardiology,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China) |
| Abstract: | Acute myocardial infarction(AMI) is a clinical disease.The measurement of biochemical markers in the blood is one of the most important methods to identify myocardial injury.Biochemical markers with their high specificity and sensitivity play an important role in diagnosis,risk stratification and prognosis of patients with AMI.Recently,many biomarkers for AMI have been used in the clinic.This article reviews current research in this field. |
| Keywords: | acute myocardial infarction biomarkers |
| 本文献已被 CNKI 万方数据 等数据库收录！ | |